Compare · head to head
Chunghwa Chemical Synthesis & Biotech vs Handok
Handok ranks higher overall — 360 rank 15 vs 13.
Handok leads on Value (51 vs 28) and Quality (52 vs 43). Chunghwa Chemical Synthesis & Biotech leads on Safety (42 vs 16). The two are close on Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Taiwan | South Korea |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | X-Small | Small |
| ISIN | TW0001762003 | KR7002390003 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 13 | 15 |
| Value | 28 | 51 |
| Quality | 43 | 52 |
| Growth | 48 | NR |
| Safety | 42 | 16 |
| Sentiment | 44 | 40 |
| Quality details | ||
| Profitability | 33 | 52 |
| Cash Truth | 53 | 51 |
Chunghwa Chemical Synthesis & Biotech vs PKCChunghwa Chemical Synthesis & Biotech vs NOVONIXChunghwa Chemical Synthesis & Biotech vs Kukje PharmaChunghwa Chemical Synthesis & Biotech vs PharmGen ScienceAdd a third stock →
Full analyses: Chunghwa Chemical Synthesis & Biotech · Handok
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100